The development of LOXO-195, a second generation TRK kinase...

European Journal of Cancer 2016 / 12 Vol. 69

The development of LOXO-195, a second generation TRK kinase inhibitor that overcomes acquired resistance to 1st generation inhibitors observed in patients with TRK-fusion cancers

Blake, J., Kolakowski, G.R., Tuch, B., Ebata, K., Brandhuber, B., Winski, S., Bouhana, K., Nanda, N., Wu, W.I., Parker, A., Hamor, R., Larsen, P.D., Sullivan, F., DeWolf, W., Neitzel, N., Wollenberg,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)33029-5
Date:
December, 2016
File:
PDF, 61 KB
english, 2016
Conversion to is in progress
Conversion to is failed